Claims
- 1. A peptide containing from 25 to 40 amino acids and comprising a sequence π corresponding to formula I:
- 2. A peptide according to claim 1, wherein the polypeptide corresponds to formula II:
- 3. A peptide according to claim 2, wherein X7, X8 or both correspond to an amino acid sequence such that the peptide of formula II has a secondary structure corresponding to an α helix.
- 4. A peptide according to claim 2 or claim 3, wherein X7 corresponds to the formula:
- 5. A peptide according to claim 4, wherein the amino acids forming the fragment contained in a sequence corresponding to amino acids 610 to 632 of a gp41 protein from an HIV-1 strain are selected from corresponding amino acids in the sequences of Tables 1 and 2.
- 6. A peptide according to claims 2, 3 or 4 wherein X8 corresponds to the formula:
- 7. A peptide according to claim 6, wherein the amino acids forming the fragment contained in a sequence corresponding to amino acids 645 to 657 of a gp41 protein from an HIV-1 strain are selected from corresponding amino acids in the sequences of Tables 1 and 2.
- 8. A therapeutic agent comprising one or more peptides according to claims 1-7 in combination with an excipient and/or a pharmaceutical carrier.
- 9. A method of treating a subject infected with HIV virus, wherein the method comprises administering to the subject a therapeutically effective amount of a therapeutic agent comprising one or more peptides of claims 1-7.
Priority Claims (1)
Number |
Date |
Country |
Kind |
0115423 |
Nov 2001 |
FR |
|
RELATED APPLICATIONS
[0001] This application claims priority to French Application No. FR 0115423 filed Nov. 29, 2001 and U.S. Provisional Application No. 60/340,492, filed Dec. 18, 2001. The contents of both applications are herein incorporate by reference in their entirety.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60340492 |
Dec 2001 |
US |